Acute Promyelocytic Leukemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Previously, we identified topoisomerase II beta (TOP2B) as a novel mediator of RA-resistance in APL cell lines.
|
20200558 |
2010 |
Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The functions of TopoIIalpha and TopoIIbeta isoforms are analyzed in peroxide-mediated DNA damage and double strand breaks (DSBs) repair in neuroblastoma and astrocytoma cells.
|
18021738 |
2008 |
Prostate carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The results indicate that detection of the TMPRSS2-ERG fusion gene and parallel immunohistochemical examination of AR, TOP2B and ERG has diagnostic significance and may be useful in assessing the biological character of the prostate cancer as well as selecting the best treatment.
|
24195515 |
2014 |
Prostate carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.
|
20601956 |
2010 |
Central neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The functions of TopoIIalpha and TopoIIbeta isoforms are analyzed in peroxide-mediated DNA damage and double strand breaks (DSBs) repair in neuroblastoma and astrocytoma cells.
|
18021738 |
2008 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
Topoisomerase IIβ-binding protein 1 (TOPBP1) participates in DNA replication and DNA damage response; however, its role in DNA repair and relevance for human cancer remain unclear.
|
26811421 |
2016 |
Childhood Neuroblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The functions of TopoIIalpha and TopoIIbeta isoforms are analyzed in peroxide-mediated DNA damage and double strand breaks (DSBs) repair in neuroblastoma and astrocytoma cells.
|
18021738 |
2008 |
Astrocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The functions of TopoIIalpha and TopoIIbeta isoforms are analyzed in peroxide-mediated DNA damage and double strand breaks (DSBs) repair in neuroblastoma and astrocytoma cells.
|
18021738 |
2008 |
Bloom Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
The Bloom syndrome helicase BLM and topoisomerase-IIβ-binding protein 1 (TopBP1) are key regulators of genome stability.
|
25794620 |
2015 |
Coughing
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The genes TOP2B and SLC4A7 and five other characterized genes that map within the critical interval have been investigated and excluded from having a pathogenic role in HSNI with cough and GER.
|
15241656 |
2004 |
Gastroesophageal reflux disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
The genes TOP2B and SLC4A7 and five other characterized genes that map within the critical interval have been investigated and excluded from having a pathogenic role in HSNI with cough and GER.
|
15241656 |
2004 |
Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, our data primarily indicate that topoIIβ can be used to estimate neuronal differentiation in MB, and may serve as a target for improving the survival rates for this condition.
|
28554742 |
2017 |
Childhood Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, our data primarily indicate that topoIIβ can be used to estimate neuronal differentiation in MB, and may serve as a target for improving the survival rates for this condition.
|
28554742 |
2017 |
Adult Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, our data primarily indicate that topoIIβ can be used to estimate neuronal differentiation in MB, and may serve as a target for improving the survival rates for this condition.
|
28554742 |
2017 |
Carcinoma of larynx
|
0.010 |
Biomarker
|
disease |
BEFREE |
The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
|
26503213 |
2016 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Topoisomerase IIβ binding protein 1 (TopBP1) is involved in DNA damage and replication checkpoint and has been shown to be related to tumorigenesis in many cancer types.
|
29028101 |
2017 |
Treatment related leukaemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity.
|
22615413 |
2012 |
Dominantly inherited sensory neuropathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
The genes TOP2B and SLC4A7 and five other characterized genes that map within the critical interval have been investigated and excluded from having a pathogenic role in HSNI with cough and GER.
|
15241656 |
2004 |
MIXED LINEAGE LEUKEMIA
|
0.010 |
Biomarker
|
disease |
BEFREE |
We show that most etoposide-induced chromosome breaks in the MLL locus and the overall genotoxicity of etoposide are dependent on topoisomerase IIβ, but that topoisomerase IIα and -β occupancy and etoposide-induced DNA cleavage data suggest factors other than local topoisomerase II concentration determine specific clustering of MLL translocation breakpoints in t-AML.
|
22615413 |
2012 |
Infant Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
In order to understand the roles of the two Top2 isozymes in and the molecular mechanism for genistein-induced infant leukemia, we carried out studies in vitro using purified recombinant human Top2 isozymes, as well as studies in cultured mouse myeloid progenitor cells (32Dc13) and Top2beta knockout mouse embryonic fibroblasts (MEFs).
|
20638367 |
2010 |
Childhood Astrocytoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The functions of TopoIIalpha and TopoIIbeta isoforms are analyzed in peroxide-mediated DNA damage and double strand breaks (DSBs) repair in neuroblastoma and astrocytoma cells.
|
18021738 |
2008 |
Carcinoma, Ovarian Epithelial
|
0.010 |
Biomarker
|
disease |
BEFREE |
While TOP2B were not found any significant prognostic value for EOC patients.
|
27315793 |
2016 |
Leukemia, Monocytic, Chronic
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.
|
16932348 |
2006 |
Myeloid Leukemia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.
|
16932348 |
2006 |
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
In contrast to topoisomerase II-alpha, topoisomerase II-beta was expressed in most normal as well as in tumor tissue samples, at a similar level.
|
8547322 |
1995 |